Bulletin
Investor Alert

Novo Nordisk A/S Series B

CSE: DK:NOVO.B

GO

/zigman2/quotes/207193277/delayed

kr.

1,049.00

Change

+22.35 +2.18%

Volume

Volume 1.93m

Mar 24, 2023, 5:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/207193277/delayed

Previous close

kr. 1,026.65

kr. 1,049.00

Change

+22.35 +2.18%

Day low

Day high

kr.1,024

kr.1,049

Open
Open: 1,025.40

52 week low

52 week high

kr.707.00

kr.1,049

Open

Market cap

kr.2362.15B

Average volume

1.54M

P/E ratio

42.93

Rev. per Employee

kr.3.25M

EPS

24.44

Dividend

8.15

Div yield

1.18%

Ex dividend date

3/24/23

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/dk/novo.b

MarketWatch News on NOVO.B

  1. Sanofi to cap price of Lantus insulin at $35

    4:24 p.m. March 16, 2023

    - Jaimy Lee

  2. Novo Nordisk lifts guidance as earnings beat expectations

    3:07 a.m. Nov. 2, 2022

    - Dominic Chopping

  3. Novo Nordisk expects deal to close in Q4

    8:05 a.m. Sept. 1, 2022

    - Ciara Linnane

  4. Novo Nordisk to acquire Forma Therapeutics in cash deal with equity value of $1.1 bln

    8:04 a.m. Sept. 1, 2022

    - Ciara Linnane

  5. Novo Nordisk upgraded to overweight from neutral at J.P. Morgan

    6:44 a.m. June 7, 2022

    - Tomi Kilgore

  6. European stocks advance after partial Russian troop withdrawal

    9:55 a.m. Feb. 15, 2022

    - Steve Goldstein

  7. Loading more headlines...
/news/nonmarketwatch/company/dk/novo.b

Other News on NOVO.B

  1. Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

    10:54 a.m. Jan. 22, 2018

    - The Wall Street Journal Interactive Edition

/news/pressrelease/company/dk/novo.b

Press Releases on NOVO.B

No News currently available for NOVO.B

Rates »

Link to MarketWatch's Slice.